You are currently viewing a beta version of our website. If you spot anything unusual, kindly let us know.
Altmetrics
Downloads
268
Views
69
Comments
0
This version is not peer-reviewed
Free-Cog [10] | Mini-Addenbrooke’s Cognitive Examination (MACE) [8] | |
---|---|---|
“Cognitive Function” | ||
General Knowledge | 1 | - |
Orientation: Time | 3 | 4 |
Orientation: Place | 3 | - |
Registration | 0 (5 words) |
7 (7-item name and address, scored on third presentation) |
Calculation | 3 | - |
Attention/Concentration | 2 | - |
Memory recall: | 5 (Recall of previously presented 5 words) |
7 (Recall of previously presented 7-item name and address) |
Verbal fluency in 1 minute | 1 (semantic: animals) |
7 (phonemic: P words) |
Language: Naming | 2 | - |
Language: Repetition | 1 | - |
Language: write a sentence | 1 | - |
Visuospatial abilities: Wire (Necker) cube | - | - |
Visuospatial abilities: Clock drawing test | 3 | 5 |
“Executive Function” | ||
5 (questions relating to social function, travel, home, emergency, and care function) | - | |
Total Score | 30 | 30 |
Cognitive impairment (dementia plus MCI) versus no cognitive impairment (SMC) | |
---|---|
Whole cohort: | |
N (dementia plus MCI vs SMC) | 141 (60 vs 81) |
F:M (%F) | 61:80 (43.3%) |
Prevalence (P = pre-test probability) |
Dementia plus MCI 0.426 |
Pre-test odds (= P/1 – P) |
Dementia plus MCI 0.741 |
Cohort aged ≥65 years: | |
N (dementia plus MCI vs SMC) | 65 (44 vs 21) |
F:M (%F) | 31:34 (47.7%) |
Prevalence (P = pre-test probability) |
Dementia plus MCI 0.677 |
Pre-test odds (= P/1 – P) |
Dementia plus MCI 2.095 |
Cohort aged ≥75 years: | |
N (dementia plus MCI vs SMC) | 25 (22 vs 3) |
F:M (%F) | 14:11 (56.0%) |
Prevalence (P = pre-test probability) |
Dementia plus MCI 0.880 |
Pre-test odds (= P/1 – P) |
Dementia plus MCI 7.333 |
Whole cohort | Older patients aged ≥65 years |
Older patients aged ≥75 years |
|
---|---|---|---|
N | 141 | 65 | 25 |
Age:Free-Cog correlation | -0.28 | -0.31 | -0.38 |
Sensitivity (Sens) |
1.00 | 0.73 (0.60-0.86) |
0.73 (0.56-0.91) |
Specificity (Spec) |
0.67 (0.59-0.76) |
0.95 (0.86-1.00) |
1.00 |
Positive Predictive Value (PPV) | 0.27 (0.15-0.38) |
0.97 (0.63-1.00) |
1.00 |
Negative Predictive Value (NPV) | 1.00 | 0.63 (0.46-0.79) |
0.33 (0.03-0.64) |
Correct classification accuracy (Acc) | 0.71 (0.63-0.78) |
0.8 (0.70-0.90) |
0.76 (0.59-0.93) |
Efficiency Index (EI) | 2.45 | 4.0 | 3.17 |
Age cohort (years) |
N | Gender F:M (% female) | Prevalence (P) | Pre-test odds | Age:MACE correlation |
---|---|---|---|---|---|
<50 | 159 | 80:79 (50.3%) | 0.088 | 0.097 | -0.11 |
50-54 | 99 | 50:49 (50.5%) | 0.232 | 0.303 | -0.00 |
55-59 | 97 | 46:51 (47.4%) | 0.381 | 0.617 | -0.04 |
60-64 | 113 | 41:72 (36.3%) | 0.434 | 0.766 | -0.05 |
65-69 | 101 | 37:64 (36.6%) | 0.515 | 1.061 | -0.08 |
70-74 | 67 | 29:38 (43.3%) | 0.776 | 3.467 | 0.02 |
75-79 | 60 | 38:22 (63.3%) | 0.967 | 29.0 | -0.00 |
≥80 | 59 | 31:28 (52.5%) | 0.898 | 8.833 | 0.01 |
Whole | 755 | 352:403 (46.6%) | 0.151 | 0.178 | -0.29 |
Age cohort | Sens | Spec | PPV | NPV | Acc | EI |
---|---|---|---|---|---|---|
<50 | 0.64 (0.39-0.89) |
0.81 (0.75-0.88) |
0.25 (0.11-0.39) |
0.96 (0.92-0.99) |
0.80 (0.74-0.86) |
3.97 |
50-54 | 0.78 (0.61-0.95) |
0.80 (0.71-0.89) |
0.55 (0.38-0.72) |
0.92 (0.86-0.99) |
0.80 (0.72-0.88) |
3.80 |
55-59 | 0.73 (0.59-0.87) |
0.78 (0.68-0.89) |
0.68 (0.53-0.82) |
0.82 (0.73-0.92) |
0.76 (0.68-0.85) |
3.22 |
60-64 | 0.61 (0.48-0.75) |
0.83 (0.74-0.92) |
0.73 (0.60-0.87) |
0.74 (0.63-0.84) |
0.73 (0.65-0.82) |
2.77 |
65-69 | 0.50 (0.36-0.64) |
0.98 (0.94-1.00) |
0.96 (0.89-1.00) |
0.65 (0.54-0.76) |
0.73 (0.65-0.82) |
2.74 |
70-74 | 0.67 (0.55-0.80) |
1.00 |
1.00 |
0.47 (0.30-0.64) |
0.75 (0.64-0.85) |
2.94 |
75-79 | 0.67 (0.55-0.79) |
1.00 |
1.00 |
0.10 (0.00-0.22) |
0.68 (0.57-0.80) |
2.16 |
≥80 | 0.77 (0.66-0.89) |
1.00 |
1.00 | 0.33 (0.12-0.55) |
0.80 (0.69-0.90) |
3.92 |
Whole cohort |
0.67 (0.62-0.72) |
0.84 (0.80-0.87) |
0.77 (0.72-0.82) |
0.76 (0.72-0.80) |
0.76 (0.73-0.79) |
3.19 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Submitted:
11 April 2023
Posted:
12 April 2023
You are already at the latest version
This version is not peer-reviewed
Submitted:
11 April 2023
Posted:
12 April 2023
You are already at the latest version
Free-Cog [10] | Mini-Addenbrooke’s Cognitive Examination (MACE) [8] | |
---|---|---|
“Cognitive Function” | ||
General Knowledge | 1 | - |
Orientation: Time | 3 | 4 |
Orientation: Place | 3 | - |
Registration | 0 (5 words) |
7 (7-item name and address, scored on third presentation) |
Calculation | 3 | - |
Attention/Concentration | 2 | - |
Memory recall: | 5 (Recall of previously presented 5 words) |
7 (Recall of previously presented 7-item name and address) |
Verbal fluency in 1 minute | 1 (semantic: animals) |
7 (phonemic: P words) |
Language: Naming | 2 | - |
Language: Repetition | 1 | - |
Language: write a sentence | 1 | - |
Visuospatial abilities: Wire (Necker) cube | - | - |
Visuospatial abilities: Clock drawing test | 3 | 5 |
“Executive Function” | ||
5 (questions relating to social function, travel, home, emergency, and care function) | - | |
Total Score | 30 | 30 |
Cognitive impairment (dementia plus MCI) versus no cognitive impairment (SMC) | |
---|---|
Whole cohort: | |
N (dementia plus MCI vs SMC) | 141 (60 vs 81) |
F:M (%F) | 61:80 (43.3%) |
Prevalence (P = pre-test probability) |
Dementia plus MCI 0.426 |
Pre-test odds (= P/1 – P) |
Dementia plus MCI 0.741 |
Cohort aged ≥65 years: | |
N (dementia plus MCI vs SMC) | 65 (44 vs 21) |
F:M (%F) | 31:34 (47.7%) |
Prevalence (P = pre-test probability) |
Dementia plus MCI 0.677 |
Pre-test odds (= P/1 – P) |
Dementia plus MCI 2.095 |
Cohort aged ≥75 years: | |
N (dementia plus MCI vs SMC) | 25 (22 vs 3) |
F:M (%F) | 14:11 (56.0%) |
Prevalence (P = pre-test probability) |
Dementia plus MCI 0.880 |
Pre-test odds (= P/1 – P) |
Dementia plus MCI 7.333 |
Whole cohort | Older patients aged ≥65 years |
Older patients aged ≥75 years |
|
---|---|---|---|
N | 141 | 65 | 25 |
Age:Free-Cog correlation | -0.28 | -0.31 | -0.38 |
Sensitivity (Sens) |
1.00 | 0.73 (0.60-0.86) |
0.73 (0.56-0.91) |
Specificity (Spec) |
0.67 (0.59-0.76) |
0.95 (0.86-1.00) |
1.00 |
Positive Predictive Value (PPV) | 0.27 (0.15-0.38) |
0.97 (0.63-1.00) |
1.00 |
Negative Predictive Value (NPV) | 1.00 | 0.63 (0.46-0.79) |
0.33 (0.03-0.64) |
Correct classification accuracy (Acc) | 0.71 (0.63-0.78) |
0.8 (0.70-0.90) |
0.76 (0.59-0.93) |
Efficiency Index (EI) | 2.45 | 4.0 | 3.17 |
Age cohort (years) |
N | Gender F:M (% female) | Prevalence (P) | Pre-test odds | Age:MACE correlation |
---|---|---|---|---|---|
<50 | 159 | 80:79 (50.3%) | 0.088 | 0.097 | -0.11 |
50-54 | 99 | 50:49 (50.5%) | 0.232 | 0.303 | -0.00 |
55-59 | 97 | 46:51 (47.4%) | 0.381 | 0.617 | -0.04 |
60-64 | 113 | 41:72 (36.3%) | 0.434 | 0.766 | -0.05 |
65-69 | 101 | 37:64 (36.6%) | 0.515 | 1.061 | -0.08 |
70-74 | 67 | 29:38 (43.3%) | 0.776 | 3.467 | 0.02 |
75-79 | 60 | 38:22 (63.3%) | 0.967 | 29.0 | -0.00 |
≥80 | 59 | 31:28 (52.5%) | 0.898 | 8.833 | 0.01 |
Whole | 755 | 352:403 (46.6%) | 0.151 | 0.178 | -0.29 |
Age cohort | Sens | Spec | PPV | NPV | Acc | EI |
---|---|---|---|---|---|---|
<50 | 0.64 (0.39-0.89) |
0.81 (0.75-0.88) |
0.25 (0.11-0.39) |
0.96 (0.92-0.99) |
0.80 (0.74-0.86) |
3.97 |
50-54 | 0.78 (0.61-0.95) |
0.80 (0.71-0.89) |
0.55 (0.38-0.72) |
0.92 (0.86-0.99) |
0.80 (0.72-0.88) |
3.80 |
55-59 | 0.73 (0.59-0.87) |
0.78 (0.68-0.89) |
0.68 (0.53-0.82) |
0.82 (0.73-0.92) |
0.76 (0.68-0.85) |
3.22 |
60-64 | 0.61 (0.48-0.75) |
0.83 (0.74-0.92) |
0.73 (0.60-0.87) |
0.74 (0.63-0.84) |
0.73 (0.65-0.82) |
2.77 |
65-69 | 0.50 (0.36-0.64) |
0.98 (0.94-1.00) |
0.96 (0.89-1.00) |
0.65 (0.54-0.76) |
0.73 (0.65-0.82) |
2.74 |
70-74 | 0.67 (0.55-0.80) |
1.00 |
1.00 |
0.47 (0.30-0.64) |
0.75 (0.64-0.85) |
2.94 |
75-79 | 0.67 (0.55-0.79) |
1.00 |
1.00 |
0.10 (0.00-0.22) |
0.68 (0.57-0.80) |
2.16 |
≥80 | 0.77 (0.66-0.89) |
1.00 |
1.00 | 0.33 (0.12-0.55) |
0.80 (0.69-0.90) |
3.92 |
Whole cohort |
0.67 (0.62-0.72) |
0.84 (0.80-0.87) |
0.77 (0.72-0.82) |
0.76 (0.72-0.80) |
0.76 (0.73-0.79) |
3.19 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Saadet Koc Okudur
et al.
Diagnostics,
2019
Mohammad Rezaei
et al.
IJERPH,
2021
Rónán O’Caoimh
et al.
Diagnostics,
2019
© 2024 MDPI (Basel, Switzerland) unless otherwise stated